A number of staff and students from Ludwig Oxford were delighted to attend the American Association for Cancer Research Annual Meeting 2024 in April at the San Diego Convention Center. The AACR Annual Meeting is a focal point of the cancer research community, and scientists, clinicians, patients, advocates and others gather to share the latest advances in cancer science and medicine.
Ludwig Oxford’s Professor Richard White presented his work on ‘What determines oncogenic competence?’ whilst Professor Benjamin Schuster-Boeckler showcased how ‘A cell-free DNA methylation biomarker outperforms irRECIST in predicting treatment outcome.
Students and Post-Doctoral researchers from the Lu and Ratcliffe teams also showcased their recent work in both posters and talks. Hannah Fuchs, a clinical DPhil student working with Professor Xin Lu demonstrated results from the recent LUD2015-005 clinical trial, where high tumour monocyte content predicts long-term survival for some patients treated with neoadjuvant immunochemotherapy.
The Ratcliffe lab were represented by Post-Doctoral researchers Samvid Kurlekar – showcasing how ‘HIF1A and HIF2A differentially contribute to early and adaptive changes following in vivo Vhl inactivation in the kidney’, and Olivia Lombardi who presented her work on ‘Transcriptional programs underpinning reoccurring cancer cell states, plasticity and tumour phylogenies in clear cell kidney cancer’.
Post-Doctoral researcher Joanna Correia Lima of the Ratcliffe lab also gave her talk titled ‘Identification of early oncogenic lesions following concomitant Vhl and Pbrm1 loss in the murine kidney’ in the CME Minisymposia.
We thank the AACR team for organising such a wonderful event and for allowing the research of the Ludwig Oxford Branch to be shared with the cancer science community.
Please note all photography credits to Unmesh Kher, Editorial Director at Ludwig Cancer Research.